Gabapentinoid use, risks, and the impact of reclassification for chronic pain patients in the United Kingdom
Background: Chronic pain is a significant health concern in the UK, leading to increased use of pregabalin and gabapentin beyond their original indications for epilepsy, anxiety, and neuropathic pain. This expanded, often unlicensed use has raised concerns due to limited efficacy evidence and misuse...
| Main Author: | |
|---|---|
| Format: | Thesis (University of Nottingham only) |
| Language: | English |
| Published: |
2024
|
| Subjects: | |
| Online Access: | https://eprints.nottingham.ac.uk/78523/ |